elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35210513-42DF630B-947F-48C6-B036-FF6AD75A1094
Q35210513-42DF630B-947F-48C6-B036-FF6AD75A1094
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35210513-42DF630B-947F-48C6-B036-FF6AD75A1094
Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes.
P2860
Q35210513-42DF630B-947F-48C6-B036-FF6AD75A1094
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35210513-42DF630B-947F-48C6-B036-FF6AD75A1094
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
063efe038ec6306ed81412b16b978eb783e18859
P2860
Clinical studies of CS-866, the newest angiotensin II receptor antagonist.